Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Licensing the first reduced, 6 µg dose whole virion, aluminum adjuvanted seasonal influenza vaccine - A randomized-controlled multicenter trial.

Vajo Z, Kalabay L, Vajo P, Balaton G, Rozsa N, Torzsa P.

Vaccine. 2019 Jan 7;37(2):258-264. doi: 10.1016/j.vaccine.2018.11.039. Epub 2018 Nov 27.

PMID:
30497837
2.

[Safety data of the new, reduced-dose influenza vaccine FluArt after its first season on the market].

Vajó P, Gyurján O, Szabó ÁM, Kalabay L, Vajó Z, Torzsa P.

Orv Hetil. 2017 Dec;158(49):1953-1959. doi: 10.1556/650.2017.30877. Hungarian.

PMID:
29199437
3.

Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial.

Vajo Z, Balaton G, Vajo P, Kalabay L, Erdman A, Torzsa P.

Br J Clin Pharmacol. 2017 Sep;83(9):1912-1920. doi: 10.1111/bcp.13289. Epub 2017 Apr 11.

4.

Pulseless electrical activity in pulmonary embolism treated with thrombolysis (from the "PEAPETT" study).

Sharifi M, Berger J, Beeston P, Bay C, Vajo Z, Javadpoor S; “PEAPETT” investigators.

Am J Emerg Med. 2016 Oct;34(10):1963-1967. doi: 10.1016/j.ajem.2016.06.094. Epub 2016 Jun 30.

PMID:
27422214
5.

Transforming and simplifying the treatment of pulmonary embolism: "safe dose" thrombolysis plus new oral anticoagulants.

Sharifi M, Vajo Z, Freeman W, Bay C, Sharifi M, Schwartz F.

Lung. 2015 Jun;193(3):369-74. doi: 10.1007/s00408-015-9702-1. Epub 2015 Mar 7.

PMID:
25749665
6.

New oral anticoagulants in the treatment of heparin-induced thrombocytopenia.

Sharifi M, Bay C, Vajo Z, Freeman W, Sharifi M, Schwartz F.

Thromb Res. 2015 Apr;135(4):607-9. doi: 10.1016/j.thromres.2015.01.009. Epub 2015 Jan 10.

PMID:
25613925
7.

Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination.

Sarkadi J, Jankovics M, Kis Z, Skare J, Fodor K, Gonczol E, Visontai I, Vajo Z, Jankovics I.

Arch Virol. 2013 Dec;158(12):2577-81. doi: 10.1007/s00705-013-1754-z. Epub 2013 Jun 15.

8.

A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trial.

Vajo Z, Tamas F, Jankovics I.

Clin Vaccine Immunol. 2012 Mar;19(3):313-8. doi: 10.1128/CVI.05619-11. Epub 2012 Jan 4.

9.

The seasonal influenza vaccine Agriflu(®).

Vajo Z.

Expert Rev Vaccines. 2011 Nov;10(11):1513-7. doi: 10.1586/erv.11.133.

PMID:
22043951
10.
11.

A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development.

Vajo Z, Wood J, Kosa L, Szilvasy I, Paragh G, Pauliny Z, Bartha K, Visontay I, Kis A, Jankovics I.

J Virol. 2010 Feb;84(3):1237-42. doi: 10.1128/JVI.01894-09. Epub 2009 Nov 11.

12.

Prevalence and distribution of permanent canine agenesis in dental paediatric and orthodontic patients in Hungary.

Rózsa N, Nagy K, Vajó Z, Gábris K, Soós A, Alberth M, Tarján I.

Eur J Orthod. 2009 Aug;31(4):374-9. doi: 10.1093/ejo/cjp018. Epub 2009 May 27.

PMID:
19474230
13.

Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?

Vajo Z, Kosa L, Szilvasy I, Pauliny Z, Bartha K, Visontay I, Jankovics M, Kis A, Jankovics I.

Influenza Other Respir Viruses. 2008 Nov;2(6):221-8. doi: 10.1111/j.1750-2659.2008.00055.x.

14.

Cardiovascular risk status and primary prevention in postmenopausal women: the MENOCARD study.

Vajo Z, Acs N, Toth K, Dinya E, Paragh G, Csaszar A.

Wien Klin Wochenschr. 2009;121(5-6):202-8. doi: 10.1007/s00508-009-1152-4.

PMID:
19412750
15.

Influenza A (H5N1) pandemic prototype vaccine Fluval.

Vajo Z.

Expert Rev Vaccines. 2009 May;8(5):619-24. doi: 10.1586/erv.09.25. Review.

PMID:
19397418
17.

Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children.

Vajo Z, Kosa L, Szilvasy I, Pauliny Z, Bartha K, Visontay I, Kis A, Tarjan I, Rozsa N, Jankovics I.

Pediatr Infect Dis J. 2008 Dec;27(12):1052-6. doi: 10.1097/INF.0b013e3181861dd7.

PMID:
18978514
18.

[Our experience with the preparation of fixed segmented bridges with nonrigid extracoronally placed connectors. Case series].

Kiss E, Gali I, Anikó GB, Vajo Z, Nagy K.

Fogorv Sz. 2008 Apr;101(2):71-3. Hungarian.

PMID:
18664098
19.

Complex care by multiple medical and dental specialists of a patient with aggressive Gorlin-Goltz syndrome.

Nagy K, Kiss E, Erdei C, Oberna F, Fejérdy P, Márton K, Vajo Z.

Postgrad Med J. 2008 Jun;84(992):330-2. doi: 10.1136/pgmj.2007.066282.

PMID:
18644927
20.

Cutaneous granuloma and uveitis caused by a tattoo.

Barabasi Z, Kiss E, Balaton G, Vajo Z.

Wien Klin Wochenschr. 2008;120(1-2):18. doi: 10.1007/s00508-007-0900-6. No abstract available.

PMID:
18239986
21.

Inactivated whole virus influenza A (H5N1) vaccine.

Vajo Z, Kosa L, Visontay I, Jankovics M, Jankovics I.

Emerg Infect Dis. 2007 May;13(5):807-8. No abstract available.

22.

[Orthodontic and oral surgery therapy in cleidocranial dysplasia].

Balaton G, Tarján I, Balaton P, Barabási Z, Gyulai Gál S, Nagy K, Vajó Z.

Fogorv Sz. 2007 Feb;100(1):17-21. Hungarian.

PMID:
17444132
23.

Echocardiographic findings in patients with Williams-Beuren syndrome.

Scheiber D, Fekete G, Urban Z, Tarjan I, Balaton G, Kosa L, Nagy K, Vajo Z.

Wien Klin Wochenschr. 2006 Sep;118(17-18):538-42.

PMID:
17009066
24.

Uterine leiomyosarcoma with osteoclast like giant cells and long standing systemic symptoms.

Patai K, Illyes G, Varbiro S, Gidai J, Kosa L, Vajo Z.

Gynecol Oncol. 2006 Aug;102(2):403-5. Epub 2006 Apr 27.

PMID:
16643995
25.

The role of dental evaluation and cephalometric analysis in the diagnosis of Williams-Beuren syndrome.

Tarjan I, Balaton G, Balaton P, Vajo Z.

Wien Klin Wochenschr. 2005 Mar;117(5-6):226-8.

PMID:
15875763
26.

Effect of simvastatin on endothelial function in cardiac syndrome X patients.

Fábián E, Varga A, Picano E, Vajo Z, Rónaszéki A, Csanády M.

Am J Cardiol. 2004 Sep 1;94(5):652-5.

PMID:
15342302
27.

Estrogen replacement therapy reverses changes in intramural coronary resistance arteries caused by female sex hormone depletion.

Mericli M, Nádasy GL, Szekeres M, Várbíró S, Vajo Z, Mátrai M, Acs N, Monos E, Székács B.

Cardiovasc Res. 2004 Feb 1;61(2):317-24.

PMID:
14736548
28.

Managing lipid disorders: further evaluation of the VA-HIT.

Vajo Z, Reaven PD; Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

Curr Diab Rep. 2003 Jun;3(3):245-7. No abstract available.

PMID:
12762973
29.

Facial and dental appearance of Williams syndrome.

Tarjan I, Balaton G, Balaton P, Varbiro S, Vajo Z.

Postgrad Med J. 2003 Apr;79(930):241. No abstract available.

30.

The effects of postmenopausal hormone replacement therapy on hemostatic variables: a meta-analysis of 46 studies.

Acs N, Vajo Z, Miklos Z, Siklosi G, Paulin F, Felicetta JV, Székåcs B.

Gynecol Endocrinol. 2002 Aug;16(4):335-46.

PMID:
12396563
31.

Advances in the treatment of diabetes-insulin analogues.

Vajo Z, Duckworth WC.

Minerva Endocrinol. 2002 Sep;27(3):167-80. Review.

PMID:
12091792
32.

Sex hormone replacement therapy reverses altered venous contractility in rats after pharmacological ovariectomy.

Várbíró S, Vajó Z, Nádasy GL, Monos E, Acs N, Lóránt M, Felicetta JV, Székacs B.

Menopause. 2002 Mar-Apr;9(2):122-6.

PMID:
11875331
33.
34.

Recombinant DNA technology in the treatment of diabetes: insulin analogs.

Vajo Z, Fawcett J, Duckworth WC.

Endocr Rev. 2001 Oct;22(5):706-17. Review.

PMID:
11588149
35.

Sex hormone replacement therapy reverses decreased venous distensibility in pharmacologically ovariectomized rats.

Várbíró S, Nádasy GL, Monos E, Acs N, Vajo Z, Székács B.

Menopause. 2001 May-Jun;8(3):204-9.

PMID:
11355043
36.

Hormone replacement reduces elevated in vivo venous tone in hypertensive ovariectomized rats.

Varbiro S, Vajo Z, Nadasy GL, Monos E, Acs N, Szekacs B.

J Soc Gynecol Investig. 2001 Mar-Apr;8(2):98-103.

PMID:
11336881
37.
38.

Insulin and analogue effects on protein degradation in different cell types. Dissociation between binding and activity.

Fawcett J, Hamel FG, Bennett RG, Vajo Z, Duckworth WC.

J Biol Chem. 2001 Apr 13;276(15):11552-8. Epub 2000 Dec 14.

39.

Effect of ovariectomy and hormone replacement therapy on small artery biomechanics in angiotensin-induced hypertension in rats.

Várbíró S, Nádasy GL, Monos E, Vajó Z, Acs N, Miklós Z, Tökés AM, Székács B.

J Hypertens. 2000 Nov;18(11):1587-95.

PMID:
11081771
40.

Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension.

Szekacs B, Vajo Z, Varbiro S, Kakucs R, Vaslaki L, Acs N, Mucsi I, Brinton EA.

BJOG. 2000 Aug;107(8):1017-21.

41.

Alterations of venous drug reactivity in humans: acquired and genetic factors.

Vajo Z, Szekacs B, Dachman W.

Angiology. 2000 May;51(5):361-6. Review.

PMID:
10826852
42.

For debate: defective mitochondria, free radicals, cell death, aging-reality or myth-ochondria?

Rustin P, von Kleist-Retzow JC, Vajo Z, Rotig A, Munnich A.

Mech Ageing Dev. 2000 Apr 14;114(3):201-6. Review.

PMID:
10802124
43.

Postmenopausal hormone replacement therapy and cardiovascular mortality in Central-Eastern Europe.

Acs N, Vajo Z, Miklos Z, Siklósi G, Paulin F, Szekacs B.

J Gerontol A Biol Sci Med Sci. 2000 Mar;55(3):M160-2.

PMID:
10795729
44.

Genetically engineered insulin analogs: diabetes in the new millenium.

Vajo Z, Duckworth WC.

Pharmacol Rev. 2000 Mar;52(1):1-9. Review.

PMID:
10699152
46.

Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension.

Szekacs B, Vajo Z, Acs N, Hada P, Csuzi L, Bezeredi J, Magyar Z, Brinton EA.

Menopause. 2000 Jan-Feb;7(1):31-5.

PMID:
10646701
47.

Conservation of the Caenorhabditis elegans timing gene clk-1 from yeast to human: a gene required for ubiquinone biosynthesis with potential implications for aging.

Vajo Z, King LM, Jonassen T, Wilkin DJ, Ho N, Munnich A, Clarke CF, Francomano CA.

Mamm Genome. 1999 Oct;10(10):1000-4.

PMID:
10501970
48.

Diuretics for hypertension.

Szekacs B, Vajo Z, Szepezdi Z.

JAMA. 1999 Aug 11;282(6):524; author reply 525. No abstract available.

PMID:
10450708
49.

Paradoxically enhanced bradykinin-induced venodilation in young, healthy, short-term smokers.

Vajo Z, Szekacs B, McDonald MH, Takahashi B, Srivathsan K, Dachman WD.

J Cardiovasc Pharmacol. 1999 Aug;34(2):316-9.

PMID:
10445684
50.

Decreased beta2 adrenergic mediated venodilatation in Native Americans.

Vajo Z, Cruz E, Szekacs B, Dachman W.

Int Angiol. 1998 Dec;17(4):276-81.

PMID:
10204662

Supplemental Content

Support Center